AJMC July 19, 2024
Andrew Cournoyer discusses how introducing payers into clinical trials earlier could help make the introduction of new technologies into the space more efficient and less time-consuming.
Andrew Cournoyer, senior vice president and director of the access experience team at Precision AQ, spoke with The American Journal of Managed Care® about how introducing payers into clinical spaces earlier could have a positive effect on the introduction of new technologies.
This transcript has been lightly edited for clarity.
Transcript
Can more time for payers affect price negotiations when it comes to new technologies?
So I think with new technologies coming to market, I’m not sure necessarily it would extend the time to bring a product to market with the new technology by...
Today's Sponsors
Today's Sponsor